iHub My Stocks Activity
Ticker Buzz Cloud
Most Followed Members
Top PlusOneCoin Posters
Data Tools >
Price & News Alerts
Markets in 3D
More Tools >
My Image Gallery
Personal Finance Q&A
PLUS1 Info & Faucet
Mining Profit Calculator
Aequus Pharmaceuticals (AQSZF)
Add AQSZF Price Alert
Search This Board:
9/4/2018 1:20:57 PM
- Board type:
- Posts Today:
Update April 8, 2017
Aequus Pharma (AQS.V) (AQSZF)
Market-Cap: c$17 Million (US$12 Million)
Cash: c$5.1 Million << enough untill mid 2018
Shares out: 71 Million
>>>>>>NEW interview with Ceo // May, 2017<<<<<<
MUST WATCH to realize the mega potential here
Lots of new Product in-licensing on the way to drive this unknown gem to profitability quickly ( see chart below ):
AQSZF (MC US$ 15M) 2 Marketed Drugs + 3 close to Approval including a Potential Blockbuster = SUPER LIFETIME OPPORTUNITY -
This undiscovered low float rocket is definitely the cheapest Biotech Gem you can get at this time. This Stock has 10 bagger Potential easily with all the Big Drugs close to Market entry .Get some of this Goldmine before she gets discovered .Management alone holding over 16 Million shares Ceo bought 840k shares at 0.30 just a few days ago .GLTA
Presentation November 2016
UPCOMING MILESTONE 2017 :
AQS1301 topline results in 1Q
File for CDN approval of Topiramate XR in 1H 2017
File for CDN approval of Oxcarbazepine XR in 1H 2017
Additional Product acquisitions in 2017
Partnership for AQS1301 in 2017
Operational profitability estimated in 2017
Two products launches to date (Tacrolimus IR and Vistitan™)
3 long-acting, transdermal programs in development, on track to file NDA in 2018
Tacrolimus IR : Aequus initiated promotional efforts for tacrolimus IR in December, 2015 •Tacrolimus products currently account for ~30% of a $300 million immunosuppressive market in Canada •Aequus is promoting the first to market generic version of Prograf (tacrolimus IR)
Vistitan : Aequus initiated commercial activities in Q2 2016 for Vistitan (bimatoprost 0.03%) •The Canadian glaucoma market in 2014 was estimated to be over $137 million, of which prostaglandins remain one of the primary treatment options.
NDA Filing for AQS-1301:Expected 3Q2017 Expected Commercial License (If Bioequivalence demonstrated in Phase I, Registration Study may NOT be required for Approval of AQS1301)
AQS-1301, a transdermal aripiprazole product candidate in development for potential weekly use in the treatment of irritability associated with autistic disorder, bipolar I disorder, schizophrenia and major depressive disorder. The currently available dosage forms of aripiprazole (sold primarily under the trade name Abilify®) reached total worldwide sales of over $8 billion USD in 2014. A once-weekly transdermal patch has the potential to improve medication adherence and reduce the frequency of relapse.
Podcast: Aequus Pharmaceuticals CEO Doug Janzen on the low cost of drug commercialization in Canada
James West: Sure. Have you built a pharmaceutical company before, Doug?
I have. So I’ve been in this industry for 20 years. I was a banker, then I ran a therapeutic company called Cardiome Pharma; I built that from 50 million to over 1 billion at its peak, and exited after doing an $800 million license with Merck — still the largest license transaction in Canadian history.
James West: Sure. Let me ask that another way: how do you plan to get to – I mean, how many of these deals can you do a year?
We bought our commercial infrastructure last July, and since then we’ve launched two products and we’ve just licensed the two Supernus programs. Those four products, we think an aggregate can do $40 million, $45 million at peak sales.
AQSZF Detailed Quote
Post New Msg
My Stocks (6)
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
Fully agree. GLTA GW
09/04/18 01:20:56 PM
Awesome company led by a smart CEO with
09/03/18 07:03:11 PM
Aequus Reports 5th Consecutive Quarter of Revenue Growth
08/27/18 08:51:31 AM
Aequus Announces Expansion of Market Opportunity for its
07/19/18 09:49:18 AM
Aequus and Corium Join Forces to Advance Anti-Nausea
06/21/18 09:23:29 AM
Aequus Announces First Canadian Cataract Procedures Using Zepto
06/18/18 09:06:27 AM
Aequus Provides First Quarter 2018 Financial and Corporate Highlights
05/31/18 10:09:13 AM
How big of a market for this product?
05/17/18 04:11:50 AM
Aequus Announces Official Launch of Zepto Capsulotomy System
05/16/18 09:45:10 AM
Sell the news again ? Can't seem to
05/04/18 10:07:17 AM
05/03/18 06:11:44 PM
Aequus Receives Positive FDA Regulatory Guidance for Anti-Nausea Patch
05/03/18 10:05:30 AM
Super news, for the soon to explode, Canadian
04/27/18 07:05:23 PM
03/21/18 04:08:11 AM
Great article, Chaka, thanks for posting!
03/19/18 09:11:05 PM
03/19/18 08:52:42 AM
In time this "fledgling" will take flight.....and soar!!!
03/17/18 07:43:37 PM
WOW! GIGANTIC ARTICLE INDEED!
03/14/18 03:31:17 AM
A must Read!
The Biggest Biotech Trends Analysts
03/13/18 05:33:44 PM
$AQSZF on the move again ......
02/16/18 10:53:30 AM
Taking a bit of a bath here as
02/02/18 02:40:22 PM
Aequus and Camargo Prepare for Meeting with FDA
01/31/18 09:33:27 AM
CannaRoyalty and Aequus Pharmaceuticals Announce Joint Venture to
01/11/18 07:48:31 AM
Coulda shoulda woulda. Thought about this a
01/03/18 10:13:45 AM
watch this bad boy run!!
01/03/18 06:08:59 AM
NO NEWS & UP THIS MUCH?
01/03/18 12:07:27 AM
Dilly Dilly ... ;-)
01/02/18 02:17:19 PM
01/02/18 02:01:14 PM
.25 now , on a roll ..... ;-)
01/02/18 11:09:48 AM
Ton of insider buying lately ... $AQSZF
01/02/18 07:51:54 AM
Looking much better here ... Will it last ???
12/05/17 08:59:57 AM
Management Discussion and Analysis
11/30/17 01:38:45 AM
Interim Financial Report :
11/30/17 01:37:48 AM
Sell some product
, willya ???
11/17/17 09:46:49 AM
Aequus Granted European Patent for Once-Weekly Transdermal Aripiprazole
11/16/17 10:18:28 AM
Aequus Granted Chinese Patent for Once-Weekly Transdermal Aripiprazole
10/10/17 09:42:21 AM
Some pre-market strength this morning .
09/21/17 09:21:02 AM
Sell the news ?? WTF ?
09/08/17 11:49:22 AM
This stock is perfect for LONG INVESTOR'S that
09/07/17 04:47:53 PM
Aequus Announces Positive Results for Proof of Concept
09/07/17 02:35:16 PM
Aequus Provides Second Quarter 2017 Operational Highlights
08/30/17 01:44:34 AM
Aequus and Ehave Collaborate on Bioinformatics Platform for
08/28/17 11:31:36 AM
Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole[/b
08/24/17 10:19:18 AM
SP isn't looking so good lately ... ;-(
08/21/17 10:16:17 AM
Does anybody have any info relating to the
08/20/17 09:57:33 PM
Aequus and Scientus Agree to Terms for a
08/01/17 11:04:45 AM
Aequus Receives Approval from Health Canada to Initiate
07/05/17 09:44:10 AM
Aequus Advances Clinical Development of Transdermal Anti-Nausea Patch
06/15/17 09:53:18 AM
Santen and Aequus Enter Into a Commercial Collaboration
06/13/17 09:21:09 AM
Halted this morning .. Not sure why yet ...
06/13/17 09:12:37 AM
Post New Msg
My Stocks (6)
Get FREE PlusOneCoins!
© 2018 InvestorsHub.com, Inc.
Terms of Service
Advertise With Us
Stock Market 101
Investor Help Forum
Personal Finance Q&A
iHub on Facebook
iHub on Twitter
iHub iPhone/iPad App
iHub Android App
iHub BlackBerry App